Dr CK Narayan of Chart Advise has a buy call on Biocon Ltd. with a target price of Rs 633. The current market price of Biocon Ltd. is Rs 623.3. Time period given by the analyst is Intra Day when Biocon Ltd. price can reach the defined target. Dr CK Narayan recommended to keep stoploss at Rs 615. Biocon Ltd., incorporated in 1978, is a largecap company with a market cap of Rs 37398.00 crore.
Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals which contributed Rs 2375.70 Crore to Sales Value (90.73 % of Total Sales), Other Operating Revenue which contributed Rs 197.10 Crore to Sales Value (7.52 % of Total Sales), Sale of services which contributed Rs 32.90 Crore to Sales Value (1.25 % of Total Sales) and Waste which contributed Rs 12.70 Crore to Sales Value (0.48 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 1123.80 Crore, down -3.91 % from last quarter Sales of Rs 1169.50 Crore and up 21.18 % from last year same quarter Sales of Rs 927.40 Crore Company has reported net profit after tax of Rs 137.80 Crore in latest quarter. The companys top management includes Dr.Arun Chandavarkar, Dr.Jeremy Levin, Dr.Vijay Kuchroo, Mr.Bobby Kanubhai Parikh, Mr.Daniel M Bradbury, Mr.John Shaw, Mr.Kiran Mazumdar Shaw, Mr.M Damodaran, Mr.Mary Harney, Mr.Russel Walls, Prof.Ravi Mazumdar. Company has B S R & Co. LLP as its auditoRs As on 30-06-2018, the company has a total of 600,000,000 shares outstanding.
[contf] [contfnew] 
ET Markets
[contfnewc] [contfnewc]
